| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 275K | $242K | $0.88 | Mar 14, 2023 | Direct |
| SAB Biotherapeutics, Inc. | CHIEF MEDICAL OFFICER | Employee Stock Option (right to buy) | 140K | Feb 21, 2024 | Direct | ||
| iBio, Inc. | Director | Stock Option (right to buy) | 109K | Dec 9, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | Feb 21, 2024 | 1 | $0 | 4 | Feb 23, 2024 | CHIEF MEDICAL OFFICER |
| SABS | SAB Biotherapeutics, Inc. | Mar 14, 2023 | 1 | $0 | 4 | Mar 16, 2023 | Chief Medical Officer |
| SABS | SAB Biotherapeutics, Inc. | Sep 13, 2022 | 1 | $0 | 4 | Sep 15, 2022 | Chief Medical Officer |
| SABS | SAB Biotherapeutics, Inc. | Jun 6, 2022 | 1 | $0 | 4 | Jun 7, 2022 | Chief Medical Officer |
| SABS | SAB Biotherapeutics, Inc. | Jun 6, 2022 | 0 | $0 | 3 | Jun 7, 2022 | Chief Medical Officer |
| IBIO | iBio, Inc. | Dec 9, 2021 | 1 | $0 | 4 | Dec 13, 2021 | Director |